Mega Genomics Limited (HKG:6667)
Hong Kong
· Delayed Price · Currency is HKD 6.70
-0.61 (-8.34%)
Mar 10, 2026, 3:30 PM HKT
Mega Genomics Revenue
Mega Genomics had revenue of 81.28M CNY in the half year ending June 30, 2025, with 68.95% growth. This brings the company's revenue in the last twelve months to 138.22M, down -13.46% year-over-year. In the year 2024, Mega Genomics had annual revenue of 164.23M with 8.54% growth.
Revenue (ttm)
138.22M CNY
Revenue Growth
-13.46%
P/S Ratio
10.83
Revenue / Employee
680.87K CNY
Employees
203
Market Cap
1.64B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kindstar Globalgene Technology | 998.42M |
| Biosino Bio-Technology and Science Incorporation | 246.61M |
| Guanze Medical Information Industry (Holding) | 161.70M |
| Adicon Holdings | 2.98B |
| China Biotech Services Holdings | 76.93M |
| Yunkang Group | 706.95M |
| King International Investment | 77.50M |
| China Health Group | 32.63M |